519 - Efficacy of prolonged ruxolitinib cream treatment for vitiligo among patients with limited or no initial response at 6 months
Sign Up to like & getrecommendations! Published in 2024 at "British Journal of Dermatology"
DOI: 10.1093/bjd/ljad498.067
Abstract: Vitiligo is a chronic autoimmune disease characterized by melanocyte destruction, leading to skin depigmentation. Limited data are available regarding the efficacy of long-term topical vitiligo treatment. In 2 randomized, double-blinded, vehicle-controlled phase 3 studies in… read more here.
Keywords: week; among patients; vasi; repigmentation ... See more keywords
Characteristics and decreased VASI of vitiligo patients with NB-UVB phototherapy in Yogyakarta, Indonesia
Sign Up to like & getrecommendations! Published in 2023 at "Dermatology Reports"
DOI: 10.4081/dr.2023.9708
Abstract: Narrowband ultraviolet-B (NB-UVB) phototherapy is the mainstay of vitiligo therapy. The response can be evaluated using the vitiligo area scoring index (VASI) and repigmentation grade. However, few studies used VASI to evaluate phototherapy response and… read more here.
Keywords: vasi; phototherapy; uvb phototherapy; reduction ... See more keywords